2. Academic Validation
  3. Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models

Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models

  • J Med Chem. 2010 Mar 25;53(6):2622-35. doi: 10.1021/jm901868z.
Elisa Nuti 1,  Francesca Casalini,  Stanislava I Avramova,  Salvatore Santamaria,  Marina Fabbi,  Silvano Ferrini,  Luciana Marinelli,  Valeria La Pietra,  Vittorio Limongelli,  Ettore Novellino,  Giovanni Cercignani,  Elisabetta Orlandini,  Susanna Nencetti,  Armando Rossello
Affiliations

Affiliation

  • 1 Dipartimento di Scienze Farmaceutiche, Università di Pisa, via Bonanno 6, 56126 Pisa, Italy.
PMID: 20180536 DOI: 10.1021/jm901868z
Abstract

Activated leukocyte cell adhesion molecule (ALCAM) plays a relevant role in tumor biology and progression. Our previous studies showed that ALCAM is expressed at the surface of epithelial ovarian Cancer (EOC) cells and is released in a soluble form by ADAM-17-mediated shedding. This process is relevant to EOC cell motility and invasiveness, which is reduced by nonspecific inhibitors of ADAM-17. For this reason, ADAM-17 may represent a new useful target in Anticancer therapy. Herein, we report the synthesis and biological evaluation of new ADAM-17 inhibitors containing an arylsulfonamidic scaffold. Among the new potential inhibitors, two very promising compounds 17 and 18 were discovered, with a nanomolar activity for ADAM-17 isolated Enzyme. These compounds proved to be also the most potent in inhibiting soluble ALCAM release in Cancer cells, showing a nanomolar activity on A2774 and SKOV3 cell lines.

Figures
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z